These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11061880)

  • 1. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.
    Ueda T; Tamaki M; Ogawa O; Yamauchi T; Yoshimura N
    J Urol; 2000 Dec; 164(6):1917-20. PubMed ID: 11061880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
    Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
    BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
    Boucher W; Kempuraj D; Cao J; Papaliodis D; Theoharides TC
    J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
    Watanabe M; Yamaguchi K; Yamanishi T; Kamai T; Yoshida K
    Hinyokika Kiyo; 2009 Nov; 55(11):715-9. PubMed ID: 19946192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
    Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
    Koda A; Yanagihara Y; Matsuura N
    Agents Actions Suppl; 1991; 34():369-78. PubMed ID: 1665310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.
    Yanagihara Y; Kiniwa M; Ikizawa K; Shida T; Matsuura N; Koda A
    Jpn J Pharmacol; 1993 Jan; 61(1):31-9. PubMed ID: 8382323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
    Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
    Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
    Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response.
    Yanagihara Y; Kiniwa M; Ikizawa K; Yamaya H; Shida T; Matsuura N; Koda A
    Jpn J Pharmacol; 1993 Jan; 61(1):23-30. PubMed ID: 8382322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
    Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
    Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
    Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M
    Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
    Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
    Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.
    Nickel JC; Tripp D; Teal V; Propert KJ; Burks D; Foster HE; Hanno P; Mayer R; Payne CK; Peters KM; Kusek JW; Nyberg LM;
    J Urol; 2007 May; 177(5):1832-6. PubMed ID: 17437831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
    Chuang YC; Lee WC; Lee WC; Chiang PH
    J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells.
    Hsu LW; Yang CH; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Tsao FK; Chen CL
    Transpl Immunol; 2007 Nov; 18(2):108-14. PubMed ID: 18005853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.
    Korting GE; Smith SD; Wheeler MA; Weiss RM; Foster HE
    J Urol; 1999 Feb; 161(2):558-65. PubMed ID: 9915448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.